What is the clinical evidence from this study?

Study design: Observational. Population: Scrub typhus (n=145). Intervention: Elevated IL-13 levels vs. Lower IL-13 levels (mild disease). Primary outcome: Moderate-severe scrub typhus (OR 1.181, 95% CI 1.039-1.343, p=0.011).

March 3, 2026Open Access

High levels of Interleukin − 13 in patients with scrub typhus correlate with disease severity

Key Result

Elevated serum IL-13 levels were significantly associated with an increased risk of moderate-severe scrub typhus (OR 1.181), suggesting its potential as an early biomarker for disease progression.

Key Points

Elevated interleukin-13 levels correlate with moderate-severe disease in scrub typhus patients, highlighting its importance.
Patients with moderate-severe illness show significantly higher IL-13, GM-CSF, and various clinical indicators compared to mild cases.
Retrospective analysis of cytokine levels was conducted in 145 patients, which included severe and mild scrub typhus cases, alongside healthy controls for comparison purposes. Four cytokines were notably elevated and could indicate disease progression, making early detection crucial to enhance patient outcomes.

Study Design

Type

Observational (n=145)

Multicenter

Yes

Structured PICO

Do serum cytokine levels correlate with disease severity in patients with scrub typhus?

Population

Patients with moderate-severe scrub typhus (n=51), mild scrub typhus (n=32), and healthy controls (n=62)

Comparator

Healthy controls and mild scrub typhus cases

Outcome

Serum cytokine levels (including IL-13 and GM-CSF) and their correlation with disease severitysurrogate

Elevated IL-13 levels may serve as an early biomarker for predicting the progression of scrub typhus to moderate-severe disease.

Main Result

Effect estimate: OR 1.181 (95% CI 1.039-1.343)

p-value: p=0.011

Limitations

The sample size in this study was limited.
The significant correlation between cytokine levels and clinical progression does not imply causation.
Findings require validation and refinement through broader regional sampling and larger-scale data analyses.

Abstract

Abstract Scrub typhus is a zoonotic infectious disease caused by Orientia tsutsugamushi infection. It has a high fatality rate if not treated in time. Currently, there are still limited reliable biomarkers for predicting the disease progression of scrub typhus. A Retrospective Analysis of the Clinical Features of Scrub Typhus and the Exploration of Early Indicators for Progression to Moderate-Severe Disease. Using the Luminex method, we quantified ten cytokines in the serum of patients with moderate-severe scrub typhus (n = 51), mild scrub typhus (n = 32), and healthy controls (n = 62). We compared serum cytokine levels, clinical manifestations, and laboratory indicators between groups and analyzed their correlations to identify early clinical indicators of progression to moderate-severe scrub typhus. Moderate-severe patients exhibited elevated GM-CSF and IL-13 versus mild cases. This group also showed higher WBC, NC count, LDH, CRP, and reduced RBC, PLT, HGB, HCT, and ALB. IL-13 correlated positively with WBC, NC count, AST, CRP and inversely with RBC, HGB, HCT, TP, ALB. Elevated IL-13 correlates with the occurrence of moderate - severe scrub typhus. Elevated IL-13 levels may serve as an early indicator for scrub typhus progression to moderate-severe disease. Early diagnosis and treatment for patients with a tendency toward moderate-severe scrub typhus are essential in order to reduce the case-fatality rate.

Bookmark

View Full Paper